Introduction
Gem (Maguire et al., 1994) , Rad (Reynet and Kahn, 1993) and Rem (Finlin and Andres, 1997) are members of a small GTP binding family of proteins within the Ras superfamily, sometimes referred to as the RGK (for Rad, Gem, and the mouse ortholog of Gem, Kir) family. The basic structure of RGK proteins consists of a Ras-related core, a non-CAAX containing carboxylterminal extension, and amino-terminal extensions. The G3 motifs (DXXG) of RGK proteins are nonconserved relative to other small GTPases, consistent with their low intrinsic GTPase activity (Cohen et al., 1994; Finlin et al., 2000) . It appears likely that either the function of RGK proteins is not regulated via GTP hydrolysis or that there is a unique mechanism for GTPase activating protein (GAP) catalyzed GTP hydrolysis relative to other Ras superfamily members. Other potential mechanisms for modulating RGK protein activity include transcriptional regulation, described for Gem (Maguire et al., 1994) and Rem (Finlin and Andres, 1997) , and phosphorylation, described for Gem, Rad, and Rem (Maguire et al., 1994; Moyers et al., 1998; Finlin and Andres, 1999) .
The RGK proteins share many structural features, which suggest common mechanisms of regulation. However, like other Ras superfamily members, Gem, Rad, and Rem have relatively unique sequences in their putative eector binding regions, implying distinct protein binding capacities. Overexpression of mouse Gem was found to induce invasive pseudohyphal growth in Saccharomyces cerevisiae (Dorin et al., 1995) . Although there is no apparent Gem ortholog in yeast, this assay most likely re¯ects the interaction of Gem with a protein common to yeast and mammalian cells. Ges, the likely human ortholog of mouse Rem, and Rem recently were described to induce endothelial cell sprouting (Pan et al., 2000) . Speci®c biochemical functions for the RGK proteins are as yet unknown.
Gem expression is highly regulated; Gem has been shown to be an immediate early gene in primary lymphocytes, monocytes, endothelial cells and human embryonic ®broblasts (Maguire et al., 1994; Vanhove et al., 1997) . Gem RNA has been detected in several dierent human and murine tissues including thymus, spleen, kidney, lung and testis (Maguire et al., 1994) . In contrast to primary cells, Gem expression was not detectable in a variety of human hematopoietic tumorderived lines including T cells, B cells, myeloid, and erythroid cell lines, either before or after treatment with PMA (Maguire et al., 1994) . Lack of expression in hematopoietic cancers may result from cells being in the wrong dierentiation state or from a loss of signaling pathways associated with transformation.
Contrary to a lack of Gem expression in epithelial and hematopoietic cancer cell lines, here we describe the constitutive expression of Gem in neuroblastoma cell lines. In clinical samples of neuroblastoma, the highest levels of Gem expression were observed in cells undergoing gangliocytic dierentiation. Signi®cantly, we show that one aspect of neuronal morphological dierentiation, neurite extension, is induced in N1E-115 and SH-SY5Y neuroblastoma cells following ectopic Gem expression.
Results

Constitutive Gem expression in melanoma and neuroblastoma cells in culture
We searched for a cell type that constitutively expresses detectable Gem in order to identify a system in which Gem function could be uniquely investigated. Constitutive Gem RNA expression was identi®ed in ®ve out of ®ve human neuroblastoma cell lines ( Figure 1a and not shown) and two of three melanoma cell lines (Figure 1a) , suggesting a frequent association of Gem expression with tumors of neuroectodermal origin. Gem was only sporadically detected in various epithelial cancers (Figure 1a ). Gem protein expression was con®rmed in the neuroblastomas, SH-SY5Y, SK-N-SH, SMS-KCNR, and CHP-126 (Figure 1b) . Gem protein was also present in the mouse neuroblastoma N1E-115 (Figure 1c) . Treatment of N1E-115 cells with DMSO resulted in morphological dierentiation of the cells that reached a plateau on day 4 (not shown) as previously described (Kimhi et al., 1976) . Following DMSO treatment, Gem protein transiently decreased and subsequently increased above nontreated levels, peaking on day 4 in parallel with morphological dierentiation.
Muscarinic receptor induction of Gem expression in neuroblastoma cells
Because Gem is known to be transcriptionally regulated by receptor-mediated activation in lymphoid and endothelial cells, we assessed Gem expression following treatment of SH-SY5Y neuroblastoma cells with various ligands which bind neuronal receptors including NMDA, kainate, and carbachol. Carbachol, an acetylcholine analog that has been demonstrated to be an activator of G protein coupled muscarinic receptors (Wess et al., 1997) , increased Gem protein above the constitutive expression level in various experiments between 4-and 10-fold ( Figure 2a ). Gem protein levels varied in parallel to Gem RNA (not shown). Gem was also induced approximately 10-fold by PMA treatment of SH-SY5Y (Figure 2a A time course of carbachol-treatment ( Figure 2b ) revealed a transient pattern of Gem expression peaking at approximately 4 h and returning to baseline by 24 h. In order to determine the speci®city of carbacholinduced Gem expression, SH-SY5Y cells were stimulated with carbachol for 4 h in the presence or absence of various drugs and subsequently assayed for Gem protein levels. Atropine, which is a competitive antagonist of muscarinic cholinergic synapses in the central and peripheral nervous system, potently blocked carbachol-induced Gem expression suggesting receptor speci®city (Figure 2c ). Neither cholera toxin, an inhibitor of Gas, nor pertussis toxin, an inhibitor of Gai family members and Gao, demonstrated a reproducible eect on Gem induction stimulated by carbachol (Figure 2c ), implying the activation of toxin insensitive G alpha subunits such as Gaq. In contrast to SH-SY5Y cells, carbachol treatment did not eect the level of Gem protein expression in N1E-115 cells, possibly re¯ecting dierences in the signaling pathways engaged downstream of muscarinic receptors in the two cell lines.
Pattern of Gem protein expression in situ in clinical specimens of neuroblastoma
In order to gain a broader understanding of the pattern of Gem expression in neuroblastoma, we used immunohistochemistry to investigate Gem expression in clinical specimens of neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Speci®city of the antiGem antibody was assessed on Western blots by comparing reactivity toward Gem and its related family members, Rem (Finlin and Andres, 1997) and Rad (Reynet and Kahn, 1993) . As shown in Figure 3 , the anti-Gem antibody bound strongly to Gem, did not bind detectably to Rad, and bound barely detectably to Rem. By comparison, antibodies directed against GST bound equally to the recombinant Gem, Rem, and Rad fusion proteins (Figure 3) . Quantitation of the signals generated following binding of the Gem-directed antibodies showed at least a 100-fold increased binding to Gem as compared to Rem.
Diagnoses (Table 1 ) of the neuroblastoma cases were established on the basis of the histopathologic criteria recommended by the International Neuroblastoma Pathology Committee . Seven cases were diagnosed as neuroblastoma with variable gangliocytic dierentiation (undierentiated, poorly dierentiated, and dierentiating). The eighth case showed, in addition, a prominent Schwann cell component accompanying mature neurites and was classi®ed as ganglioneuroblastoma, intermixed. In another section, this latter case exhibited entirely mature elements, i.e. ganglion cells, Schwann cells and neurites conforming to a ganglioneuroma. Gangliocytic dierentiation is de®ned by the presence of cells with variable but usually abundant pink cytoplasm and eccentrically localized nuclei with prominent nucleoli (Figure 4a, b) . In all specimens examined in this study, immunostaining for Gem was observed speci®cally and almost exclusively in cells with gangliocytic dierentiation (Figure 4c ). The latter exhibited a universally strong, granular pattern of staining (inset Figure 4c) . The one neuroblastoma in this series that lacked ganglion cell dierentiation was negative for Gem in this assay, consistent with the observation that poorly dierentiated neuroblastic cells were negative for Gem on almost all histologic sections. The only exception was case seven, in which poorly dierentiated tumor cells stained weakly positive for Gem. Interestingly, ganglion cells at their ®nal stages of dierentiation showed weaker positivity for Gem (Figure 4d,f) , in contrast to their dierentiative counterparts. This was more obvious in the ganglioneuroma section, in which only weak ganglion cell staining for Gem was observed (Figure 4e ). In two neuroblastomas, Gem-positive spindle cells were additionally observed in the thin septal portion of the supportive stroma that surrounds the neuroblastic lobules (Figure 4f ). The immunostaining results are summarized in Table 1 . No Gem immunoreactivity was observed in specimens stained Figure 3 The speci®city of Anti-Gem antibodies. Recombinant GST-Gem, Gst-Rad, and GST-Rem proteins were puri®ed and equal amounts of protein were separated on an SDS gel and subsequently assayed in a Western blot for reactivity to anti-GST or anti-Gem antibodies which had been absorbed and anity puri®ed as detailed in Materials and methods 
Gem protein expression in developing mouse ganglia
The high levels of Gem expressed in tumor cells that had begun to dierentiate to a ganglionic morphology suggested that Gem might normally be expressed in dierentiating or dierentiated neurons. Therefore, we used immunohistochemistry to investigate Gem protein expression in the mouse in adult and fetal adrenal glands and in developing ganglia. There was no detectable Gem expression in either adult or fetal adrenal medulla (not shown), consistent with the low level of expression in undierentiated neuroblastoma. Serial transverse sections through the heads of 12.5 day mouse embryos were stained with antibodies directed against Gem or tyrosine hydroxylase (TH) ( Figure 5 ). In the adult PNS, TH expression occurs in sympathetic ganglia, sensory ganglia, a subpopulation of dorsal root ganglia neurons, some parasympathetic neurons, and neuroendocrine adrenal chroman cells (Son et al., 1996) . The embryonic PNS contains additional cells that transiently express TH, including cells within the cranial sensory and dorsal root ganglia. Speci®c Gem expression was detected in various developing structures within the head, some of which were ganglia as determined by morphology and positive staining with antibody directed to TH. The trigeminal (shown in Figure 5a ± d) and dorsal root ganglia were clearly identi®ed adjacent to the pars anterior of the pituitary gland (Figure 5a ) and the rostral portion of the central canal, respectively. Gem was readily detectable in the trigeminal ganglia ( Figure  5c ) and less so in the dorsal root ganglia (not shown). Therefore, Gem is expressed in a population of normal developing PNS neurons.
Ectopic Gem expression stimulates neurite extension in neuroblastoma cells
The potential mechanistic importance of Gem expression in dierentiating neuroblastoma was investigated in a mouse neuroblastoma, N1E-115 cells, that are permissive for ecient gene transfer and are poised to undergo neurite remodeling (Hirose et al., 1998; Katoh et al., 1998) . N1E-115 cells adhere only loosely to glass or plastic, and therefore, we found it dicult to reproducibly perform immunohistochemistry with such cells. As an alternative, we co-transfected N1E-115 cells with DNA encoding Green Fluorescent Protein (GFP) as a marker of transfection along with Gem. Western blot analyses veri®ed increased Gem expression following transfection (data not shown). As a control of the system, we also cotransfected DNA encoding GFP and ROK that previously has been shown to induce neurite retraction in N1E-115 cells (Hirose et al., 1998; Katoh et al., 1998) . Twenty-four hours following transfection,¯uorescent cells were scored for morphology in the presence of serum as either round cells,¯at cells with short neurites, or cells with long neurites (Figure 6a ). N1E-115 cells normally are heteromorphic;¯uorescent cells cotransfected with empty vector alone demonstrated approximately half the cells in a rounded state and half the cells in ā attened state, with a small number of cells (4%) displaying long neurites. Importantly, Gem expression stimulated neurite extension. There was a signi®cant loss of rounded cells from 48 to 13% and a concomitant increase in cells with short and long neurites. The speci®city of Gem in this assay is supported by the ®nding that transfection of Rem, a related protein, had no eect despite its expression as determined by Western blotting (Figure 6a ).
RasS17N is a widely used point mutant with dominant negative activity. Based upon the conservation of a homologous serine at positions 17 and 89 in Ras and Gem, respectively, we constructed GemS89N. Baccuolvirus-produced recombinant GemS89N had reduced guanine nucleotide anity (not shown), as does RasS17N (Cool et al., 1999) . However, GemS89N maintained functional activity in the neurite extension assay (Figure 6a ). The dominant negative activity of RasS17N appears to be particularly dependent upon an inability to interact with eectors (Cool et al., 1999) , a property that may not have been lost in GemS89N.
As expected, ectopic expression of ROK resulted in neurite retraction and cell rounding in virtually all of the transfected cells (Figure 6a ). An epistasis assay with cotransfected Gem and ROK showed a reversal of ROK-mediated cell rounding, suggesting that Gem acts downstream of or in parallel with ROK (Figure 6a) . We conclude that in N1E-115 cells, increased Gem Similarly, Gem transfection of human SH-SY5Y cells (Figure 6b ) increased morphological dierentiation as measured by cell¯attening and neurite extension. Up to 60% of untreated or vectortransfected SH-SY5Y cells are¯at. Gem expression eectively stimulated long neurites in these cells and partially reversed ROK-mediated cell rounding.
Discussion
The physiological role of Gem is unknown. We describe here a functional assay for Gem, i.e. the stimulation of neurite outgrowth by ectopic expression of Gem in N1E-115 and SH-SY5Y neuroblastoma cells. These results strongly imply that one function of Gem relates to cytoskeletal reorganization and/or morphological dierentiation of neurons. We were led to consider such an assay by the observation that high Gem expression correlates with the dierentiation of immature cells to a gangliocytic morphology in clinical specimens of human neuroblastoma. In neuroblastoma, ganglioneuroblastoma and ganglioneuroma, Gem is easily detectable in cells with ganglionic morphology, being absent or minimally expressed in the precursor tumor cells with undierentiated morphology. Importantly, Gem is also expressed in ganglia of the developing mouse embryo, demonstrating that Gem expression in ganglia is a property of normal development and not a unique property of neuroblastoma.
We describe detectable constitutive expression of Gem in neuroblastoma cell lines and its transient upregulation by PMA and by the muscarinic receptor agonist, carbachol in the neuroblastoma cell line, SH-SY5Y. Thus, Gem appears to be a neurotransmitterresponsive immediate early gene in neuronally related tissues, consistent with the highly regulated nature of Gem expression in hematopoietic and endothelial cells. Although Gem expression is upregulated, SH-SY5Y cells do not morphologically dierentiate following carbachol treatment. This is in contrast to the neurite extension induced in N1E-115 and SH-SY5Y cells by ectopic Gem expression. Perhaps the timing of Gem expression is critical, and sustained Gem expression, as would be anticipated following transfection, is important. Alternatively, carbachol treatment may lead to additional signals that block morphological dierentiation.
After induction of gangliocytic dierentiation, Gem, consistent with its nature as an activation-related early response gene, may return to normal low levels, as observed in terminally dierentiated ganglion cells derived from neuroblastoma (Figure 4c ± e) . The observed Gem-positive perilobal spindle cells coincide topographically and morphologically with the S-100-positive putative Schwann cells in neuroblastoma, which have been associated with a better prognosis (Shimada et al., 1985; Hachitanda and Tsuneyoshi, 1994 ) and have been implicated by the induction of neuroblastic dierentiation (Ambros and Ambros, 1995) . How do Gem levels vary with the normal dierentiation of neurons? A detailed time course of Gem expression and/or Gem promoter activity during embryological development of PNS ganglia may provide interesting insights into the potential role of Gem in the developmental process.
Rem promotes endothelial cell (EC) sprouting, a type of cytoskeletal reorganization observed as elongated or dendrite-like morphology of EC (Pan et al., 2000) . Thus, Gem and Rem may both function in roles associated with cytoskeletal changes and morphological dierentiation. A putative dominant negative form of Rem, but not Gem, inhibited matrigel-induced morphological dierentiation of endothelial cells, implying cell type speci®city (Pan et al., 2000) . Consistent with this speci®city, Rem did not induce neurite extension in neuroblastomas (Figure 6a ). An important question is the possible mechanistic relationship of Gem expression to cytoskeletal reorganization and morphological dierentiation. Ectopic Gem expression stimulated cell¯attening and neurite extension in N1E-115 cells ( Figure 6 ). In this system, activation of RhoA and/or its eector Rho kinase (also known as ROCK or ROK) are necessary and sucient to stimulate neurite retraction (Hirose et al., 1998; Katoh et al., 1998) . Inhibition of Rho kinase has been shown to lead to neurite extension in N1E-115 cells (Hirose et al., 1998; Katoh et al., 1998) . Signi®cantly, we have demonstrated that Gem interacts with ROK in yeast two hybrid analyses (unpublished). Consistent with its retention of neurite-inducing activity, GemS89N also bound ROK. Studies are currently ongoing to investigate the mechanistic importance of the Gem-ROK interaction. The anticipation from the neurite extension observed following Gem transfection is that the activity of ROK or one of its required substrates is blocked by Gem.
Maturation in neuroblastoma is thought to be one mechanism associated with spontaneous regression. In addition, tumors with maturing neuroblasts and Schwannian stromal development (ganglioneuroblastoma, intermixed and ganglioneuroma) have a favorable prognosis . The induction of new gene expression, especially in a cell type-speci®c way, and consequent modulation of signaling pathways that impact upon morphological dierentiation is a therapeutic modality to be considered in neuroblastoma and other types of cancer. The metastatic potential of neuroblastoma expressing ectopic Gem currently is being investigated in a mouse model. to the melanomas, Mel-397, Mel-4 and Mel-501 were a gift from Dr F Marincola (NCI, NIH). The cell lines MCF-10 (immortalized mammary epithelial), MCF-7 and MDA-231 (mammary cancer), Hela (cervical cancer) and OVCAR-3 (ovarian cancer) were provided by Dr P Steeg (NCI, NIH). Murine neuroblastoma cells (N1E-115) were obtained from the ATCC (Manassas, VA, USA). All the cell lines except the SH-SY5Y were maintained in DMEM (high glucose) with 10% FCS in an atmosphere of 5% CO 2 . The cell line SH-SY5Y was routinely cultured in RPMI (high glucose) in 10% FCS in an atmosphere of 5% CO 2 .
Carbachol, atropine, pertussis toxin, and cholera toxin were purchased from Calbiochem (La Jolla, CA, USA). Kainic acid, NMDA and all-trans retinoic acid were purchased from Sigma (St. Louis, MO, USA). GST-Rad and GST-Rem clones were the kind gifts of Ronald Kahn and Douglas Andres, respectively. DNA encoding Rhokinase in the pCAG vector was kindly provided by Dr Narumiya (Kyoto University, Japan).
Drug treatments of neuroblastoma cells
Unless speci®cally mentioned, treatments to SH-SY5Y cells were performed in RPMI with 10% FCS. The SH-SY5Y cells were grown in 6-well plates to subcon¯uency, fresh medium containing dierent inhibitors was added, and 1 h later carbachol was added at the concentration and for the length of time described in the ®gure legends. Inhibitors were used at the following concentrations: 0.5 mM atropine sulfate, 0.5 mg/ml Pertussis toxin, and 1 mg/ml Cholera toxin. Induction of morphological dierentiation in N1E-115 cells with DMSO (1% v/v) was performed as described (Kimhi et al., 1976) . Maximal morphological dierentiation which consisted of enlarged refractile cells with long, branched processes was complete by day 4.
Northern blots
Total RNA from cell lines was isolated with RNAzol (TelTest, Inc., Friedswood, TX, USA). Approximately 10 mg of total RNA were separated on a 1% agarose formaldehyde gel, transferred to Nytran ®lters (Schleicher and Schuell, Keene, NH, USA) and probed with a full-length Gem cDNA insert, 32 P-labeled with the random priming method. The ®nal wash was performed in 0.1% SSC, 0.1% SDS at 708C.
Immunoprecipitations and Western blots
Total protein was extracted in lysis buer (25 mM HEPES pH 7.4, 1% Triton X-100, 150 mM NaC1, 10% glycerol 5 mM EDTA, 1 mM PMSF, 10 mg/ml Leupeptin, 10 mg/ml Aprotinin, 25 mM b-glycerolphosphate). Immunoprecipitations were performed by incubating approximately 100 mg of total protein lysate in 500 ml of lysis buer with 2.5 mg of anti-Gem monoclonal antibody P2D10 for 3 h at 48C with mixing. The immunocomplexes were then incubated with 20 ml of packed rProtein G agarose beads (Gibco-BRL, Bethesda, MD, USA) for 2 h at 48C and washed three times in 20 volumes of lysis buer. The immunoprecipitates were resuspended in loading buer (60 mM TRIS-HCl pH 6.8, 2% SDS, 0.5% glycerol, 0.5% DTT, 0.002% Bromophenol blue), boiled for 2 min and separated on a 10% SDS polyacrylamide gel. Separated proteins were transferred to PVDF membrane (Costar, Cambridge, MA, USA) probed with an anti-Gem polyclonal antibody (270 PS) and visualized by chemilluminescence (Pierce, Rockford, IL, USA). The blots shown are representative of experiments that were repeated a minimum of three times.
Immunohistochemistry
Immunohistochemistry was performed on clinical samples of neuroblastoma and staged mouse embryos. Ten neuroblastoma tissue specimens from eight patients were randomly selected from the ®les of the Laboratory of Pathology, NCI. All cases were unlinked to patient clinical identi®ers. The heads from 12.5 day old mouse embryos were ®xed in 4% paraformaldehyde overnight, dehydrated with a graded series of ethanol and embedded in paran. Serial, ®ve micron transverse sections starting in the upper eye region were cut. Brie¯y, 5 mm paran sections were deparanized, dehydrated, treated for 30 min in methanol containing 0.5% H 2 O 2 , microwaved for 40 min in 10 mM citrate buer and then incubated for 1 h in 16% normal goat serum and overnight with anity-puri®ed anti-Gem (270PS) antibody (1 : 200 dilution), or with anti-tyrosine hydroxylase antibody (1 : 100) (Pel-Freeze, Rogers, Arkansas). The secondary antibody was then applied for 1 h at room temperature, followed by the Vectastain Elite ABC Reagent (Vector Laboratories, Burlingame, CA, USA) for 30 min. The peroxidase reaction was developed with diaminobenzidine and the slides were counterstained with hematoxylin.
270PS was raised in rabbits by repeated immunization with soluble recombinant GST-Gem protein. The antisera were absorbed with recombinant GST and recombinant GST-Rad (Reynet and Kahn, 1993) coupled to beads. Flow-through from the above columns was bound to a GST-Gem anity column, eluted with glycine buer (pH 3.5) and dialyzed against PBS. Speci®city of the anti-Gem antibody was shown in Western blots (see Figure 2) or by the inhibition of immunohistochemical labeling in the presence of an eightfold excess of recombinant Gem protein.
Neurite remodeling assay N1E-115 or SH-SY5Y cells in 35 mm dishes were cotransfected with 0.2 mg pEGFP-N1 (Clontech) and 2.5 mg eukaryotic expression vector encoding Gem or Rho kinase using the standard Lipofectamine Plus (BRL) protocol. Twenty-four hours following transfection, morphology of the cells expressing Green Fluorescence Protein (GFP) was examined on a Zeiss Axiovert microscope using the Zeiss Achrostigmat 3260.40 PH1 objective. At least 400 cells for each transfection were counted in a single experiment.
